HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Health-Care Antiseptics OTC Labeling Amendments Proposed By CTFA/SDA

This article was originally published in The Tan Sheet

Executive Summary

Labeling of antibacterial consumer hand and body products should include a "qualified" warning statement regarding children's use of such items, the Cosmetic, Toiletry & Fragrance Association and Soap & Detergent Association suggest in a citizen petition filed with FDA April 2.

You may also be interested in...

US FDA Catches Up On Monograph Petitions: Denies Antiseptic TFM Requests Made In 2001

Agency’s recent responses denying three petitions filed in 2001 by US industry trade groups and in 2002 by pharmaceutical ingredient and chemicals firm explain the changes requested can be proposed in “OTC monograph order requests” pathway established in program overhaul.

Triclocarbon Category I Antibacterial Efficacy Supported By Bayer Studies

Triclocarbon in concentrations up to 1.5% should be included as a Category I active ingredient in the healthcare antiseptic tentative final monograph, Bayer advises FDA in a 1Dec. 28 citizen petition

Antimicrobial Data Support CTFA/SDA Performance Criteria - Petition

A comprehensive literature review of topical antimicrobial data "corroborates" the suitability of the product performance criteria advocated by industry, the Cosmetic, Toiletry & Fragrance Association and Soap & Detergent Association maintain in an Aug. 6 joint submission to FDA.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts